1 Min Read
Jan 29 (Reuters) - Vistagen Therapeutics Inc:
* VISTAGEN THERAPEUTICS INC - PREPARES TO INITIATE ITS PHASE 2 STUDY OF AV-101 FOR MAJOR DEPRESSIVE DISORDER Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.